| Name | Title | Contact Details |
|---|
Ovia Health is a family health benefits platform helping women and families with personalized and data-driven solutions for fertility, pregnancy, and parenting.
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
Proprio is a Seattle company developing a system for real-time immersive video and mediated reality interaction. We are using cutting edge algorithms and custom hardware to enhance human capabilities in high precision activities such as brain surgery.
BioMS Medical Corporation is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
J. A. Thomas and Associates is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.